Skip to content

Depression: all studies

Page 206 of 1,034: studies 2,051 to 2,060 of 10,336, newest first. Back to the depression overview

Research

Meditação Vipassana sobre o estado de ansiedade, depressão e qualidade de vida de profissionais em isolamento social no período de lockdown-2020/COVID-19 (Vipassana meditation on anxiety state, depression and quality of life of professionals in social isolation in the lockdown period -2020/COVID-19) (Meditación Vipassana sobre el estado de ansiedad, depresión y calidad de vida de los profesionales en aislamiento social en el período de confinamiento-2020/COVID-19)

Retos August 17, 2022 Carlos Anderson Assis De Sousa, Rodrigo Gomes de Souza Vale, Lia Monteiro De Oliveira et al.

O objetivo deste estudo foi avaliar os efeitos de um programa de Vipassana meditação (VM) sobre estado de ansiedade, depressão e qualidade de vida (QV) de profissionais em isolamento social no período de Lockdown durante a pandemia COVID19/2020. Trata-se de um estudo experimental com intervenção baseada em exercícios de VM com medidas de pré e pós testes de grupos experimental e de controle com...

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder

The Canadian Journal of Psychiatry August 17, 2022 Joshua D. Rosenblat, Muhammad Ishrat Husain, Yena Lee et al. 58 citations

Objective Serotonergic psychedelics are re-emerging as potential novel treatments for several psychiatric disorders including major depressive disorder. The Canadian Network for Mood and Anxiety Treatments (CANMAT) convened a task force to review the evidence and provide a consensus recommendation for the clinical use of psychedelic treatments for major depressive disorder. Methods A systematic...

BDNF Alterations in Brain Areas and the Neurocircuitry Involved in the Antidepressant Effects of Ketamine in Animal Models, Suggest the Existence of a Primary Circuit of Depression

Journal of Integrative Neuroscience August 16, 2022 Ezio Carboni, Anna R. Carta 15 citations

Major depressive disorder is one of the primary causes of disability and disease worldwide. The therapy of depression is prevalently based on monoamine reuptake blockers; consequently, investigations aimed to clarify the aetiology of depression have mostly looked at brain areas innervated by monamines and brain circuitry involved in inputs and outputs of these areas. The recent approval of...

DOI: 10.31083/j.jin2105144 (opens in new tab) Serotonin Ventral tegmental area Stria terminalis Nucleus accumbens +8

The Effects of Psychoeducational Interventions Based on Mindfulness on Depression, Anxiety, and Stress Outcomes of Older Adults

Sakarya University Journal of Education August 15, 2022 Esin Tüccar, Ali Şar

People of the older ages are now the growing segment of the general population. Despite the individual diversities, older adults are perceived as associated with poor social and emotional functions. The present study aims to examine the effects of mindfulness-based psychoeducational interventions on the depression, anxiety, and stress outcomes of older adults. Thus, it highlights the...

A systematic review and meta-ethnographic synthesis of Mindfulness-based Cognitive Therapy for people with major depression.

Clinical Psychology & Psychotherapy August 15, 2022 Kate Williams, Samantha Hartley, Susanne Langer et al.

Background: Mindfulness-based Cognitive Therapy (MBCT) is a relapse-prevention intervention for people experiencing major depression. Three qualitative meta-syntheses investigating experiences of taking part in MBCT and/or Mindfulness-based Stress Reduction (MBSR) across different diagnostic populations reported themes including control, choice, group processes, relationships and struggles. As...

Mindfulness-Based Interventions for the Occurrence of Postpartum Depression in Elderly Primiparas.

Contrast media & molecular imaging August 13, 2022 Rui Mei, Fan Peng, Jing Xiong et al.

This study aimed to investigate the independent risk factors for the occurrence of postpartum depression (PPD) in elderly primiparas and the effect of mindfulness-based intervention (MBI) on improving the PPD. Two hundred cases of elderly primiparas who underwent delivery in our hospital from January 2016 to December 2019 were enrolled as study participants and divided into an occurrence group...

NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial

International Journal of Bipolar Disorders August 13, 2022 A. Nierenberg, P. Lavin, Daniel C Javitt et al.

Background We tested the hypothesis that, after initial improvement with intravenous ketamine in patients with bipolar disorder (BD) with severe depression and acute suicidal thinking or behavior, a fixed-dose combination of oral D-cycloserine (DCS) and lurasidone (NRX-101) can maintain improvement more effectively than lurasidone alone. Methods This was a multi-center, double-blind, twostage,...

Assessment of Objective and Subjective Cognitive Function in Patients With Treatment-Resistant Depression Undergoing Repeated Ketamine Infusions

The International Journal of Neuropsychopharmacology August 5, 2022 J. Phillips, A. van Geel, P. Burhunduli et al.

Abstract Background Subanesthetic ketamine infusions can elicit rapid and sustained antidepressant effects, yet the potential cognitive impact of ketamine has not been thoroughly examined. This study measured changes in objective and subjective cognitive function following repeated ketamine treatment. Methods Thirty-eight patients with treatment-resistant depression were administered cognitive...

Mindfulness Buffers the Effect of Inauthenticity on Depression

Psychological Reports August 1, 2022 Anja Roemer, Anna Sutton, Oleg N. Medvedev

Objectives: Pressures in daily life limit one’s ability to be authentic and research shows that inauthenticity can be detrimental to mental health. Mindfulness is known to have a protective effect on mental health through an accepting and nonjudgmental stance. This study aimed to establish whether mindfulness buffers the relationship between inauthenticity and depression. Method: A...

Intranasal esketamine for depression: Not so special K

Australasian Psychiatry August 1, 2022 Stephen Rosenman 2 citations

Background Intranasal esketamine has been recently approved for the treatment of resistant depression. It is the only form of ketamine approved. The formulation costs around $600 per dose while plain injected ketamine, on which most research has been done, costs less than $20 per dose. Research shows that intranasal esketamine is less effective and has more unwanted effects than injected...